{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:52:09Z","timestamp":1791975129091,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","award":["??"],"award-info":[{"award-number":["??"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1445-4","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T08:02:54Z","timestamp":1564646574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Changes in microparticle profiles by vitamin D receptor activation in chronic kidney disease \u2013 a randomized trial"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6243-6078","authenticated-orcid":false,"given":"Kristina","family":"Lundwall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefin","family":"M\u00f6rtberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz","family":"Mobarrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun","family":"J\u00f6rneskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Spaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"1445_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoya G. Clinical guidelines National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, Classificaiton, and stratification. Ann Intern Med. 2003;139:137\u201347.","journal-title":"Ann Intern Med"},{"issue":"29","key":"1445_CR2","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corr U, Cosyns B, Deaton C, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315\u201381.","journal-title":"Eur Heart J"},{"issue":"2","key":"1445_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.hfc.2013.12.003","volume":"10","author":"C Ronco","year":"2014","unstructured":"Ronco C, Di Lullo L. Cardiorenal syndrome. Heart Fail Clin. 2014;10(2):251\u201380.","journal-title":"Heart Fail Clin"},{"issue":"2","key":"1445_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1681\/ASN.2005080834","volume":"17","author":"F Stam","year":"2006","unstructured":"Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol. 2006;17(2):537\u201345.","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"1445_CR5","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","volume":"121","author":"JS Bock","year":"2010","unstructured":"Bock JS, Gottlieb SS. Cardiorenal syndrome: new perspectives. Circulation. 2010;121(23):2592\u2013600.","journal-title":"Circulation"},{"issue":"5","key":"1445_CR6","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","volume":"62","author":"J Himmelfarb","year":"2002","unstructured":"Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. Perspectives in renal medicine: the elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62(5):1524\u201338.","journal-title":"Kidney Int"},{"issue":"4","key":"1445_CR7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/bcp.12014","volume":"76","author":"O Leonard","year":"2013","unstructured":"Leonard O, Spaak J, Goldsmith D. Regression of vascular calcification in chronic kidney disease - feasible or fantasy? A review of the clinical evidence. Br J Clin Pharmacol. 2013;76(4):560\u201372.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1445_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ndt\/gfv111","volume":"31","author":"G Schlieper","year":"2016","unstructured":"Schlieper G, Schurgers L, Brandenburg V, Reutelingsperger C, Floege J. Vascular calcification in chronic kidney disease: an update. Nephrol Dial Transplant. 2016;31(1):31\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"9752","key":"1445_CR9","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","volume":"376","author":"D de Zeeuw","year":"2010","unstructured":"de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving H-H, Pritchett Y, Remuzzi G, Ritz E, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet. 2010;376(9752):1543\u201351.","journal-title":"Lancet"},{"key":"1445_CR10","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1681\/ASN.2017010003","volume":"8","author":"V Kumar","year":"2017","unstructured":"Kumar V, Yadav AK, Lal A, Kumar V, Singhal M, Billot L, Gupta KL, Banerjee D, Jha V. A randomized trial of vitamin D supplementation on vascular function in CKD. J Am Soc Nephrol. 2017;8:3100\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"1445_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2215\/CJN.10791016","volume":"12","author":"A Levin","year":"2017","unstructured":"Levin A, Tang M, Perry T, Zalunardo N, Beaulieu M, Dubland JA, Zerr K. Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD. Clin J Am Soc Nephrol. 2017;12:1\u201317.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"1445_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012;307(7):674\u201384.","journal-title":"JAMA"},{"issue":"6","key":"1445_CR13","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","volume":"59","author":"C Aranow","year":"2011","unstructured":"Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881\u20136.","journal-title":"J Investig Med"},{"issue":"September","key":"1445_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/biolre\/bio142604","volume":"96","author":"X Jia","year":"2017","unstructured":"Jia X, Xu J, Gu Y, Gu X, Li W, Wang Y. Vitamin D suppresses oxidative stress-induced microparticle release by human umbilical vein endothelial cells. Biol Reprod. 2017;96(September):199\u2013210.","journal-title":"Biol Reprod"},{"key":"1445_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12882-017-0576-8","volume":"18","author":"L Mansouri","year":"2017","unstructured":"Mansouri L, Lundwall K, Moshfegh A, Jacobson SH, Lundahl J, Spaak J. Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease \u2013 a randomized trial. BMC Nephrol. 2017;18:161.","journal-title":"BMC Nephrol"},{"issue":"1","key":"1445_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/nyas.12429","volume":"1317","author":"J Vojinovic","year":"2014","unstructured":"Vojinovic J. Vitamin D receptor agonists\u2019 anti-inflammatory properties. Ann N Y Acad Sci. 2014;1317(1):47\u201356.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"1445_CR17","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2016-3753","volume":"102","author":"J Xu","year":"2017","unstructured":"Xu J, Jia X, Gu Y. Vitamin D reduces oxidative stress \u2013 induced Procaspase-3\/ROCK1 activation and MP release by placental trophoblasts. J Clin Endocrinol Metab. 2017;102(6):2100\u201310.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1445_CR18","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1681\/ASN.2013030203","volume":"24","author":"MH De Borst","year":"2013","unstructured":"De Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJA. Active vitamin D treatment for reduction of residual proteinuria: a systematic review. J Am Soc Nephrol. 2013;24(11):1863\u201371.","journal-title":"J Am Soc Nephrol"},{"key":"1445_CR19","first-page":"320560","volume":"2013","author":"T Han","year":"2013","unstructured":"Han T, Rong G, Quan D, Shu Y, Liang Z, She N, Liu M, Yang B, Cheng G, Lv Y, et al. Meta-analysis: the efficacy and safety of paricalcitol for the treatment of secondary hyperparathyroidism and proteinuria in chronic kidney disease. Biomed Res Int. 2013;2013:320560.","journal-title":"Biomed Res Int"},{"key":"1445_CR20","first-page":"4","volume":"8","author":"L Xu","year":"2013","unstructured":"Xu L, Wan X, Huang Z, Zeng F, Wei G, Fang D, Deng W, Li Y. Impact of vitamin D on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials. PLoS One. 2013;8:4.","journal-title":"PLoS One"},{"issue":"3","key":"1445_CR21","doi-asserted-by":"publisher","first-page":"e91363","DOI":"10.1371\/journal.pone.0091363","volume":"9","author":"N Chitalia","year":"2014","unstructured":"Chitalia N, Ismail T, Tooth L, Boa F, Hampson G, Goldsmith D, Kaski JC, Banerjee D. Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients. PLoS One. 2014;9(3):e91363.","journal-title":"PLoS One"},{"issue":"4","key":"1445_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000441364","volume":"42","author":"K Lundwall","year":"2015","unstructured":"Lundwall K, J\u00f6rneskog G, Jacobson SH, Spaak J. Paricalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trial. Am J Nephrol. 2015;42(4):265\u201373.","journal-title":"Am J Nephrol"},{"issue":"5","key":"1445_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/HYPERTENSIONAHA.114.03748","volume":"64","author":"C Zoccali","year":"2014","unstructured":"Zoccali C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Politi R, Tripepi G, et al. Paricalcitol and endothelial function in chronic kidney disease trial. Hypertension. 2014;64(5):1005\u201311.","journal-title":"Hypertension"},{"key":"1445_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12882-018-1042-y","volume":"19","author":"K Lundwall","year":"2018","unstructured":"Lundwall K, Jacobson S, J\u00f6rneskog G, Spaak J. Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis. BMC Nephrol. 2018;19:247.","journal-title":"BMC Nephrol"},{"issue":"9","key":"1445_CR25","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.2215\/CJN.01870217","volume":"12","author":"J Kendrick","year":"2017","unstructured":"Kendrick J, Andrews E, You Z, Moreau K, Nowak KL, Farmer-Bailey H, Seals DR, Chonchol M. Cholecalciferol, calcitriol, and vascular function in CKD: a randomized, double-blind trial. Clin J Am Soc Nephrol. 2017;12(9):1438\u201346.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1445_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jdiacomp.2015.01.004","volume":"29","author":"TK Thethi","year":"2015","unstructured":"Thethi TK, Bajwa MA, Ghanim H, Jo C, Weir M, Gold AB, Umpierrez G, Desouza C, Dandona P, Fang-hollingsworth Y, et al. Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease. J Diabetes Complicat. 2015;29:433\u20137.","journal-title":"J Diabetes Complicat"},{"key":"1445_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"Thadhani R, Wenger J, Tamez H, Cannata J, Thompson BT, Andress D, Manning WJ, Solomon SD. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease. JAMA. 2012;307:674\u201384.","journal-title":"JAMA"},{"issue":"1","key":"1445_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1681\/ASN.2013010103","volume":"25","author":"AYM Wang","year":"2014","unstructured":"Wang AYM, Fang F, Chan J, Wen YY, Qing S, Chan IHS, Lo G, Lai KN, Lo WK, Lam CWK, et al. Effect of paricalcitol on left ventricular mass and function in CKD-the OPERA trial. J Am Soc Nephrol. 2014;25(1):175\u201386.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1445_CR29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.clinbiochem.2015.02.003","volume":"48","author":"A Berezin","year":"2015","unstructured":"Berezin A, Zulli A, Kerrigan S, Petrovic D, Kruzliak P. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases. Clin Biochem. 2015;48(9):562\u20138.","journal-title":"Clin Biochem"},{"issue":"7","key":"1445_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1042\/CS20120309","volume":"124","author":"D Burger","year":"2013","unstructured":"Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM. Microparticles: biomarkers and beyond. Clin Sci (London, England : 1979). 2013;124(7):423\u201341.","journal-title":"Clin Sci (London, England : 1979)"},{"key":"1445_CR31","doi-asserted-by":"publisher","first-page":"734509","DOI":"10.1155\/2013\/734509","volume":"2013","author":"M Markiewicz","year":"2013","unstructured":"Markiewicz M, Richard E, Marks N, Ludwicka-Bradley A. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J Aging Res. 2013;2013:734509.","journal-title":"J Aging Res"},{"issue":"1","key":"1445_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1096\/fj.14-249706","volume":"29","author":"P Buend\u00eda","year":"2015","unstructured":"Buend\u00eda P, De Oca AM, Madue\u00f1o JA, Merino A, Mart\u00edn-Malo A, Aljama P, Ram\u00edrez R, Rodr\u00edguez M, Carracedo J. Endothelial microparticles mediate inflammation-induced vascular calcification. FASEB J. 2015;29(1):173\u201381.","journal-title":"FASEB J"},{"key":"1445_CR33","doi-asserted-by":"publisher","first-page":"5047954","DOI":"10.1155\/2016\/5047954","volume":"2016","author":"D Burger","year":"2016","unstructured":"Burger D, Turner M, Munkonda MN, Touyz RM. Endothelial microparticle-derived reactive oxygen species: role in endothelial signaling and vascular function. Oxidative Med Cell Longev. 2016;2016:5047954.","journal-title":"Oxidative Med Cell Longev"},{"issue":"1","key":"1445_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1681\/ASN.2015010074","volume":"27","author":"U Erdbr\u00fcgger","year":"2016","unstructured":"Erdbr\u00fcgger U, Le TH. Extracellular vesicles in renal diseases: more than novel biomarkers? J Am Soc Nephrol. 2016;27(1):12\u201326.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1445_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0049-3848(03)00064-1","volume":"109","author":"JJ Jimenez","year":"2003","unstructured":"Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res. 2003;109(4):175\u201380.","journal-title":"Thromb Res"},{"issue":"5","key":"1445_CR36","first-page":"1096","volume":"98","author":"MN Abid Hussein","year":"2007","unstructured":"Abid Hussein MN, Boing AN, Sturk A, Hau CM, Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost. 2007;98(5):1096\u2013107.","journal-title":"Thromb Haemost"},{"issue":"3","key":"1445_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3324\/haematol.13547","volume":"94","author":"M Perez-Casal","year":"2009","unstructured":"Perez-Casal M, Downey C, Cutillas-Moreno B, Zuzel M, Fukudome K, Toh CH. Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica. 2009;94(3):387\u201394.","journal-title":"Haematologica"},{"key":"1445_CR38","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1093\/ndt\/gfp066","volume":"24","author":"I Dursun","year":"2009","unstructured":"Dursun I. The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease. Nephrol Dial Transplant. 2009;24:2511\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"1445_CR39","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1681\/ASN.2005050535","volume":"16","author":"N Amabile","year":"2005","unstructured":"Amabile N, Guerin AP, Leroyer AP, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005;16(11):3381\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1445_CR40","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1210\/jc.2006-0851","volume":"91","author":"K Esposito","year":"2006","unstructured":"Esposito K, Ciotola M, Schisano B, Gualdiero R, Sardelli L, Misso L, Giannetti G, Giugliano D. Endothelial microparticles correlate with endothelial dysfunction in obese women. J Clin Endocrinol Metab. 2006;91(9):3676\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1445_CR41","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/annrheumdis-2012-203028","volume":"73","author":"B Parker","year":"2014","unstructured":"Parker B, Al-Husain A, Pemberton P, Yates AP, Ho P, Gorodkin R, Teh LS, Alexander MY, Bruce IN. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus. Ann Rheum Dis. 2014;73(6):1144\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1445_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/jhh.2008.137","volume":"23","author":"JM Wang","year":"2009","unstructured":"Wang JM, Su C, Wang Y, Huang YJ, Yang Z, Chen L, Wu F, Xu SY, Tao J. Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients. J Hum Hypertens. 2009;23(5):307\u201315.","journal-title":"J Hum Hypertens"},{"key":"1445_CR43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","volume":"4","author":"V Faure","year":"2006","unstructured":"Faure V. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost. 2006;4:566\u201373.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"1445_CR44","doi-asserted-by":"publisher","first-page":"F1302","DOI":"10.1152\/ajprenal.00114.2014","volume":"307","author":"S Soriano","year":"2014","unstructured":"Soriano S, Carmona A, Trivi\u00f1o F, Rodriguez M, Alvarez-Benito M, Mart\u00edn-Malo A, Alvarez-Lara M-A, Ram\u00edrez R, Aljama P, Carracedo J. Endothelial damage and vascular calcification in patients with chronic kidney disease. Am J Physiol Renal Physiol. 2014;307(11):F1302\u201311.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"1445_CR45","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/ndt\/gfr474","volume":"27","author":"MC Trappenburg","year":"2012","unstructured":"Trappenburg MC, Van Schilfgaarde M, Frerichs FCP, Spronk HMH, Ten Cate H, De Fijter CWH, Terpstra WE, Leyte A. Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity. Nephrol Dial Transplant. 2012;27(4):1446\u201353.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1445_CR46","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.healun.2009.06.005","volume":"28","author":"N Amabile","year":"2009","unstructured":"Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y. Increased CD62e+ endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant. 2009;28(10):1081\u20136.","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"1445_CR47","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/ndt\/gfr573","volume":"27","author":"N Amabile","year":"2012","unstructured":"Amabile N, Gu\u00e9rin AP, Tedgui A, Boulanger CM, London GM. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dial Transplant. 2012;27(5):1873\u201380.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"1445_CR48","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/eurjhf\/hfq145","volume":"12","author":"T Nozaki","year":"2010","unstructured":"Nozaki T, Sugiyama S, Sugamura K, Ohba K, Matsuzawa Y, Konishi M, Matsubara J, Akiyama E, Sumida H, Matsui K, et al. Prognostic value of endothelial microparticles in patients with heart failure. Eur J Heart Fail. 2010;12(11):1223\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"1445_CR49","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/eurheartj\/ehq478","volume":"32","author":"JM Sinning","year":"2011","unstructured":"Sinning JM, Losch J, Walenta K, B\u00f6hm M, Nickenig G, Werner N. Circulating CD31 +\/Annexin V + microparticles correlate with cardiovascular outcomes. Eur Heart J. 2011;32(16):2034\u201341.","journal-title":"Eur Heart J"},{"issue":"9","key":"1445_CR50","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","volume":"32","author":"P Libby","year":"2012","unstructured":"Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045\u201351.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"1445_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11255-016-1275-2","volume":"48","author":"M Kocijancic","year":"2016","unstructured":"Kocijancic M, Cubranic Z, Vujicic B, Racki S, Dvornik S, Zaputovic L. Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients. Int Urol Nephrol. 2016;48(7):1145\u201354.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"1445_CR52","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/ndt\/17.3.435","volume":"17","author":"A Papayianni","year":"2002","unstructured":"Papayianni A, Alexopoulos E, Giamalis P, Gionanlis L, Belechri AM, Koukoudis P, Memmos D. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant. 2002;17(3):435\u201341.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1445_CR53","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/ndt\/15.10.1624","volume":"15","author":"P Stenvinkel","year":"2000","unstructured":"Stenvinkel P, Lindholm B, Heimburger M, Heimburger O. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant. 2000;15(10):1624\u201330.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1445_CR54","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1080\/08860220802406385","volume":"30","author":"S Bevc","year":"2008","unstructured":"Bevc S, Sabic S, Hojs R. Atherosclerosis in hemodialysis patients--the role of microinflammation. Ren Fail. 2008;30(10):1012\u20136.","journal-title":"Ren Fail"},{"issue":"1","key":"1445_CR55","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2011.12.025","volume":"221","author":"C Jung","year":"2012","unstructured":"Jung C, Sorensson P, Saleh N, Arheden H, Ryden L, Pernow J. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis. 2012;221(1):226\u201331.","journal-title":"Atherosclerosis"},{"issue":"2","key":"1445_CR56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/SHK.0000000000000823","volume":"48","author":"S Ye","year":"2017","unstructured":"Ye S, Shan X-F, Han W-Q, Zhang Q-R, Gao J, Jin A-P, Wang Y, Sun C-F, Zhang S-L. Microparticles from patients undergoing percutaneous coronary intervention impair vasodilatation by uncoupling endothelial nitric oxide synthase. Shock. 2017;48(2):201\u20138.","journal-title":"Shock"},{"issue":"1","key":"1445_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.thromres.2011.09.027","volume":"129","author":"F Mobarrez","year":"2012","unstructured":"Mobarrez F, Egberg N, Antovic J, Br\u00f6ijersen A, J\u00f6rneskog G, Wall\u00e9n H. Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study. Thromb Res. 2012;129(1):95\u20137.","journal-title":"Thromb Res"},{"issue":"6","key":"1445_CR58","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/1479164113491275","volume":"10","author":"S Tehrani","year":"2013","unstructured":"Tehrani S, Mobarrez F, Lins P-E, Adamson U, Wall\u00e9n HN, J\u00f6rneskog G. Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes. Diab Vasc Dis Res. 2013;10(6):483\u20138.","journal-title":"Diab Vasc Dis Res"},{"issue":"8","key":"1445_CR59","doi-asserted-by":"publisher","first-page":"18185","DOI":"10.3390\/ijms160818185","volume":"16","author":"S Steven","year":"2015","unstructured":"Steven S, M\u00fcnzel T, Daiber A. Exploiting the pleiotropic antioxidant effects of established drugs in cardiovascular disease. Int J Mol Sci. 2015;16(8):18185\u2013223.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1445_CR60","first-page":"109","volume":"114","author":"D Augustine","year":"2014","unstructured":"Augustine D, Ayers LV, Lima E, Newton L, Lewandowski AJ, Davis EF, Ferry B, Leeson P. Dynamic release and clearance of circulating microparticles during cardiac stress. CircRes. 2014;114(1):109\u201313.","journal-title":"CircRes"},{"issue":"1","key":"1445_CR61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/2279-042X.200994","volume":"6","author":"A Naeini","year":"2017","unstructured":"Naeini A, Moeinzadeh F, Vahdat S, Ahmadi A, Hedayati Z, Shahzeidi S. The effect of vitamin D administration on intracellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in hemodialysis patients: a placebo-controlled, double-blinded clinical trial. J Res Pharm Pract. 2017;6(1):16.","journal-title":"J Res Pharm Pract"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1445-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1445-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1445-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T19:10:35Z","timestamp":1695064235000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1445-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1445"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1445-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients provided written informed consent and the study protocol was approved by the regional Ethics Committee of Stockholm, Sweden. The trial was registered on clinicaltrials.gov (SOLID study; NCT01204528).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Abbott (now AbbVie) provided drugs and supported the study by an institutional grant. The study was investigator initiated and AbbVie has not participated in the design of the study or in practical parts, analysis, or manuscript writing. JS and KL take full responsibility for the accuracy of data and for data interpretation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}